📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The management impact of 68gallium-tris(hydroxypyridinone) prostate-specific membrane antigen (68Ga-THP-PSMA) PET-CT imaging for high-risk and biochemically recurrent prostate cancer. (2020)

First Author: Kulkarni M

Attributed to: King’s College London Confidence in Concept funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00259-019-04643-7

PubMed Identifier: 31872280

Publication URI: http://europepmc.org/abstract/MED/31872280

Type: Journal Article/Review

Volume: 47

Parent Publication: European journal of nuclear medicine and molecular imaging

Issue: 3

ISSN: 1619-7070